跳到正文
原文
Endpoints News 生物医药· Ayisha Sharma·· 2026-09-29AI 评分38

SK pharmteco 宣布投资超 2 亿美元以扩展 CDMO 能力

SK pharmteco unveils $200M+ investment to expand CDMO capabilities

AI 导读

SK pharmteco 计划在未来五年内投入至少 2 亿美元,用于建设其开发与制造基础设施,以扩展 CDMO 能力。该投资决策旨在加强公司在此领域的业务布局,文章指出此预期正在推进中。

正文

SK pharmte­co plans to spend at least $200 mil­lion on build­ing out its de­vel­op­ment and man­u­fac­tur­ing in­fra­struc­ture over the next five years, which is ex­pect­ed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news